CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-09 | Slack David W. President & CBO | Shares withheld for taxes | −3,358 | $3.00 | $10K | 20,642 |
| 2023-01-09 | Slack David W. President & CBO | Grant or award · Stock Options (Right to Buy) | +12,000 | 12,000 | ||
| 2023-01-09 | Buck Kristen K EVP, R&D and CMO | Grant or award | +18,000 | 38,482 | ||
| 2023-01-09 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −2,147 | $3.00 | $6K | 36,335 |
| 2023-01-09 | Buck Kristen K EVP, R&D and CMO | Grant or award · Stock Options (Right to Buy) | +9,000 | 9,000 | ||
| 2023-01-09 | Flowers Cynthia Louise Director | Grant or award | +20,000 | 29,721 | ||
| 2023-01-09 | BROWN GREGORY B Director | Grant or award | +20,000 | 29,934 | ||
| 2023-01-09 | Ruoslahti Erkki Director | Grant or award | +20,000 | 20,000 | ||
| 2023-01-09 | Mazzo David J Chief Executive Officer | Grant or award | +60,000 | 109,285 | ||
| 2023-01-09 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −7,845 | $3.00 | $24K | 101,440 |
| 2023-01-09 | Mazzo David J Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +30,000 | 30,000 | ||
| 2023-01-09 | AZAB MOHAMMAD Director | Grant or award | +20,000 | 39,200 | ||
| 2023-01-09 | HENSON HEIDI Director | Grant or award | +20,000 | 20,000 | ||
| 2023-01-09 | KLOSK STEVEN M Director | Grant or award | +20,000 | 30,090 | ||
| 2022-09-15 | AZAB MOHAMMAD Director | Grant or award | +19,200 | $6.25 | $120K | 19,200 |
| 2022-09-01 | Buck Kristen K EVP, R&D and CMO | Grant or award | +58,000 | $0.50 | $29K | 377,203 |
| 2022-09-01 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −25,183 | $0.50 | $13K | 352,020 |
| 2022-09-01 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −44,776 | $0.50 | $22K | 307,244 |
| 2022-09-01 | Mazzo David J Chief Executive Officer | Grant or award | +150,000 | $0.50 | $75K | 809,186 |
| 2022-09-01 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −69,742 | $0.50 | $35K | 739,444 |
Page 5 of 18 · 345 trades